Should be getting close to even this week based on its recent performance (last 4 weeks or so) or even happy if one had faith to bought-in/added under $3's, after the reverse split.
Cur could be one of the few that a reverse split helped it as a company overall regarding market prices...along with the recent press releases.
Unfortunately for me bio is ever so hard to predict. For every "Cur"(assuming it's really solidifying it's company) there's 500 losers that are nothing but jargon-hype.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.